ICU Medical (NASDAQ:ICUI) Reaches New 52-Week High at $186.00

ICU Medical, Inc. (NASDAQ:ICUI) shares reached a new 52-week high during trading on Monday . The company traded as high as $186.00 and last traded at $184.71, with a volume of 24431 shares traded. The stock had previously closed at $174.47.

Analyst Ratings Changes

Several brokerages have recently weighed in on ICUI. Needham & Company LLC restated a “hold” rating on shares of ICU Medical in a report on Thursday, August 8th. KeyCorp upped their price target on shares of ICU Medical from $136.00 to $147.00 and gave the company an “overweight” rating in a report on Thursday, August 8th. Raymond James raised their price objective on shares of ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research report on Thursday, September 12th. Finally, StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Thursday, September 12th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $149.00.

ICU Medical Stock Down 1.7 %

The company has a market capitalization of $4.36 billion, a price-to-earnings ratio of -73.12 and a beta of 0.65. The company has a quick ratio of 1.08, a current ratio of 2.41 and a debt-to-equity ratio of 0.76. The business has a 50-day moving average price of $157.00 and a 200-day moving average price of $125.33.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.56. ICU Medical had a positive return on equity of 5.01% and a negative net margin of 3.07%. The firm had revenue of $596.50 million for the quarter, compared to the consensus estimate of $556.64 million. During the same quarter in the previous year, the company earned $1.58 EPS. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. As a group, equities analysts anticipate that ICU Medical, Inc. will post 3.76 earnings per share for the current fiscal year.

Insider Activity at ICU Medical

In other ICU Medical news, VP Daniel Woolson sold 2,502 shares of ICU Medical stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $163.22, for a total transaction of $408,376.44. Following the transaction, the vice president now directly owns 13,107 shares in the company, valued at approximately $2,139,324.54. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other ICU Medical news, VP Virginia Ruth Sanzone sold 2,050 shares of ICU Medical stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $144.11, for a total value of $295,425.50. Following the completion of the sale, the vice president now directly owns 4,482 shares in the company, valued at $645,901.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Daniel Woolson sold 2,502 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $163.22, for a total transaction of $408,376.44. Following the transaction, the vice president now directly owns 13,107 shares in the company, valued at $2,139,324.54. The disclosure for this sale can be found here. In the last 90 days, insiders sold 40,552 shares of company stock worth $6,679,322. 6.70% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Innealta Capital LLC bought a new position in ICU Medical during the second quarter worth $32,000. Motco acquired a new position in shares of ICU Medical during the first quarter valued at about $29,000. GAMMA Investing LLC lifted its stake in shares of ICU Medical by 75.1% in the first quarter. GAMMA Investing LLC now owns 310 shares of the medical instruments supplier’s stock valued at $33,000 after buying an additional 133 shares during the period. EntryPoint Capital LLC grew its position in ICU Medical by 731.5% during the first quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier’s stock worth $48,000 after buying an additional 395 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its stake in ICU Medical by 46.4% during the first quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier’s stock valued at $59,000 after acquiring an additional 173 shares during the period. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.